Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome Associated with 20q Deletion

Autor: Amen Allah Nasr, Sawsen Bouzidi, Khaouala Bderi, Zeineb Ben Hassine, Samy Laayouni, Naouel Ben Salah, Najiba Fekih-Mrissa, Bassem Louzir, Brahim Nsiri

Publikováno v: Journal of Applied Hematology, Vol 15, Iss 2, Pp 152-155 (2024)

Elliptocytes are most abundant in hereditary elliptocytosis. Isolated deletion 20q [del(20q)] associated with elliptocytosis in a patient with myelodysplastic syndrome (MDS) is very rare, and only a few cases are reported in the literature. This repo

Externí odkaz: https://doaj.org/article/60fcfbcfef42414a81e761c8fc8b530d

Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion

Autor: Martín I. Castillo, Villamón E. Ribate, Calabuig M. Muñoz, Sanz G. Santillana, Such E. Taboada, Mora E. Casterá, Calasanz M. J. Abinzano, Irigoyen A. Barranco, Collado R. Nieto, Vara M. Pampliega, M. L. Blanco, Álvarez S. deAndrés, Pérez J. deOteyza, Bernal T. delCastillo, Granada I. Font, Jerez A. Cayuela, M. Díez‐Campelo, Abellán R. Sánchez, Solano C. Vercet, Tormo M. Díaz, Grupo Español de Síndromes Mielodisplásicos (GESMD)

Publikováno v: Cancer Medicine, Vol 12, Iss 16, Pp 16788-16792 (2023)

Abstract Background In myelodysplastic neoplasms (MDS), the 20q deletion [del(20q)] is a recurrent chromosomal abnormality that it has a high co‐occurrence with U2AF1 mutations. Nevertheless, the prognostic impact of U2AF1 in these MDS patients is

Externí odkaz: https://doaj.org/article/08f9708f736a4f908d833861cf715f26

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?

Autor: Campagna, Alessia¹ (AUTHOR) alessia.camp@gmail.com, De Benedittis, Daniela² (AUTHOR) danidb07@hotmail.it, Fianchi, Luana³ (AUTHOR) luana.fianchi@policlinicogemelli.it, Scalzulli, Emilia² (AUTHOR) scalzulli@bce.uniroma1.it, Rizzo, Lorenzo² (AUTHOR) rizzo@bce.uniroma1.it, Niscola, Pasquale⁴ (AUTHOR) pniscola@gmail.com, Piccioni, Anna Lina⁵ (AUTHOR) annalinapiccioni@virgilio.it, Di Veroli, Ambra⁶ (AUTHOR) ambra.diveroli@asl.vt.it, Mancini, Stefano⁷ (AUTHOR) smancini@scamilloforlanini.rm.it, Villivà, Nicoletta⁸ (AUTHOR) nicoletta.villiva@aslrm1.it, Martini, Tiziano⁹ (AUTHOR) t.martini@univpm.it, Mohamed, Sara² (AUTHOR) mohamed@bce.uniroma1.it, Carmosino, Ida² (AUTHOR) carmosino@bce.uniroma1.it, Criscuolo, Marianna³ (AUTHOR) marianna.criscuolo85@yahoo.it, Fenu, Susanna⁵ (AUTHOR) sfenu@hsangiovanni.roma.it, Aloe Spiriti, Maria Antonietta¹ (AUTHOR) mariaantoniettaaloespiriti@gmail.com, Buccisano, Francesco¹⁰ (AUTHOR) francesco.buccisano@uniroma2.it, Mancini, Marco² (AUTHOR) mancini@bce.uniroma1.it, Tafuri, Agostino¹ (AUTHOR) agostino.tafuri@ospedalesantandrea.it, Breccia, Massimo² (AUTHOR) breccia@bce.uniroma1.it

Publikováno v: Journal of Clinical Medicine. May2022, Vol. 11 Issue 9, p2596-2596. 9p.

Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations

Autor: Itziar Oiartzabal, Teresa Bernal, Carlos Solano, Eva Villamón, Míriam Gutiérrez, Rosario Abellán, Míriam Vara, María Díez-Campelo, María José Calasanz, Iván Martín, Sara Alvarez, Marisa Calabuig, Aroa Irigoyen, Guillermo Sanz, Isabel Granada, Esperanza Such, Elvira Mora, Rocío García‐Serra, Mª Laura Blanco, Rosa Collado, Rosana Diez, Andres Jerez, Blanca Xicoy, Angela Gil, Mar Tormo

Publikováno v: BRITISH JOURNAL OF HAEMATOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
British Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol

In myelodysplastic syndromes (MDS), the 20q deletion [del(20q)] may cause deletion of the ASXL1 gene. We studied 153 patients with MDS and del(20q) to assess the incidence, prognostic value and impact on response to azacitidine (AZA) of ASXL1 chromos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0e81ebf5e7444eddb0caf6e4af4054
https://doi.org/10.1111/bjh.17675

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.